sRANKL Human, His

Soluble RANK Ligand Human Recombinant, His Tag
Cat. No.
BT1052
Source
Escherichia Coli.
Synonyms

Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf, hRANKL2.

Appearance
Sterile Filtered colorless solution.
Purity
Greater than 80.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

sRANKL Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 199 amino acids (140-317 a.a) and having a molecular mass of 22.3kDa.
sRANKL is fused to a 21 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
RANKL is a protein that plays a role in bone resorption and immune regulation. It binds to two receptors, TNFRSF11B (OPG) and TNFRSF11A (RANK). RANKL is essential for the formation and activation of osteoclasts, cells responsible for breaking down bone tissue. It also enhances the ability of dendritic cells, a type of immune cell, to stimulate the proliferation of naive T cells, another type of immune cell. This suggests that RANKL may be involved in regulating interactions between T cells and dendritic cells, and may play a role in the T cell-dependent immune response. Additionally, sRANKL may be involved in the increased bone resorption seen in humoral hypercalcemia of malignancy.
Description
sRANKL Human Recombinant is a non-glycosylated polypeptide chain containing 199 amino acids (140-317 a.a). It has a molecular mass of 22.3 kDa. Produced in E. coli, it is fused to a 21 amino acid His-tag at the N-terminus for purification. The protein is purified using proprietary chromatographic techniques.
Physical Appearance
A sterile, colorless solution.
Formulation
The sRANKL protein solution has a concentration of 0.5 mg/ml and contains 20mM Tris-HCl buffer (pH 8.0), 20% glycerol, 0.1M NaCl, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), store at 4°C. For long-term storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
The purity of the sRANKL Human Recombinant is greater than 80%, as determined by SDS-PAGE.
Synonyms

Soluble Receptor Activator of NFkB Ligand, TNFSF11, TRANCE, TNF-related activation-induced cytokine, OPGL, ODF, Osteoclast differentiation factor, Tumor necrosis factor ligand superfamily member 11, Receptor activator of nuclear factor kappa B ligand, RANKL, Osteoprotegerin ligand, CD254 antigen, sRANKL, sOdf, hRANKL2.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MIRAEKAMVD GSWLDLAKRS KLEAQPFAHL TINATDIPSG SHKVSLSSWY HDRGWAKISN MTFSNGKLIV NQDGFYYLYA NICFRHHETS GDLATEYLQL MVYVTKTSIK IPSSHTLMKG GSTKYWSGNS EFHFYSINVG GFFKLRSGEE ISIEVSNPSL LDPDQDATYF GAFKVRDID.

Product Science Overview

Structure and Production

The recombinant human sRANKL is typically produced in Escherichia coli (E. coli) and purified through sequential chromatography . The protein is a non-glycosylated polypeptide chain containing 199 amino acids, with a molecular mass of approximately 22.3 kDa . The His tag, consisting of 21 amino acids, is fused to the N-terminus of the protein to facilitate purification and detection .

Biological Activity

sRANKL is known for its ability to bind to the receptor activator of nuclear factor kappa-B (RANK) on the surface of osteoclast precursors, promoting their differentiation into mature osteoclasts. This interaction is essential for bone resorption and remodeling . Additionally, sRANKL can interact with a decoy receptor called osteoprotegerin (OPG), which inhibits osteoclastogenesis by preventing sRANKL from binding to RANK .

Applications

Recombinant sRANKL is used extensively in cell culture, differentiation studies, and functional assays. It is particularly valuable in research focused on bone diseases, such as osteoporosis and rheumatoid arthritis, as well as in studies of immune system regulation . The protein’s ability to induce NF-κB activation in various cell types makes it a powerful tool for investigating signaling pathways involved in inflammation and immune responses .

Preparation and Storage

The lyophilized form of sRANKL is typically reconstituted in distilled water to a concentration of 0.1-1.0 mg/mL . For long-term storage, it is recommended to store the reconstituted solution in working aliquots at -80°C to -20°C, with a carrier protein such as 0.1% bovine serum albumin (BSA) to enhance stability . The lyophilized protein is stable at room temperature for up to one month but should be stored at -20°C for extended periods .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.